By Najat Kantouar
Deltex Medical said it would propose delisting from London's Alternative Investment Market at its next general meeting.
The medical technology group said Tuesday that it would seek approval for the delisting at its general shareholder meeting on Feb. 12.
The group has so far received letters of intent and irrevocable undertakings in favor of the proposal representing around 53.8% of the company's share capital, it said.
The cancellation is conditional upon the approval of at least 75% of the votes. If the proposal is passed at the general meeting, it will become effective on Feb. 21, Deltex said.
Write to Najat Kantouar at najat.kantouar@wsj.com
(END) Dow Jones Newswires
January 21, 2025 03:22 ET (08:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。